CORD iPS is a biotechnology company that combines modern medicine, science, and technology in order to make innovative products and services available in Serbia and customized for each client. We made it possible for clients to invest in the future health of their child in the right and safest way. Driven by the experience of the largest biomedical centers for the cryopreservation of stem cells Vita 34 and Seracell from Germany, unlocking the power of the whole genome by cooperating with Illumina from USA, and collaborating with Novogenia from Austria, we enable high-tech medical services and products to be widely available in Serbia. Exclusive agent for: CORD BLOOD INDUSTRY Seracell Stammzelltechnologie GmbH, Germany Vita34 AG, Germany GENETIC TESTING Illumina inc., USA Novogenia, Austria DNA Plus, Germany *CORD iPS is the triple-A rated company (AAA - Bisnode)
| Website | http://www.cord.rs |
| Employees | 15 (15 on RocketReach) |
| Founded | 2010 |
| Phone | +381 21 3101333 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Innovative Treatments, Regenerative Medicine, Cellular Therapies, Cell Therapy, Stem Cells, Advanced Therapies, Scientific Research, Medical Innovation, Pharmaceutical Research, Biomedical Engineering, Personalized Medicine, Drug Discovery, Clinical Trials, Healthcare Technology, Medical Technology, Life Sciences, Biotech Solutions, Therapeutic Solutions |
| Competitors | ReNeuron Group Plc, MediWound Ltd., Athersys, Celyad Oncology, Iovance Biotherapeutics, Inc., Spinal Elements, Sangamo Therapeutics, Inc., Organogenesis, Mesoblast Limited, Pluristem Therapeutics +31 more (view full list) |
Looking for a particular CORD iPS employee's phone or email?
Vladimir Jesic is the CEO of CORD iPS.
15 people are employed at CORD iPS.